stachybotrys_microspora_triprenyl_phenol-7 [Neurosurgery Wiki]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.

Stachybotrys microspora triprenyl phenol-7 (SMTP-7) is a new [[thrombolytic agent]] that exhibits anti-inflammatory effects. 

The hemorrhagic transformation was fewer with SMTP-7 than with recombinant tissue plasminogen activator (rt-PA) following ischemia-reperfusion in animal models. 

SMTP-7 decreases mortality, hemorrhagic transformation, and neurological deficits, and can be a safe thrombolytic agent following MCAO under the warfarin-treated condition
((Ito A, Niizuma K, Shimizu H, Fujimura M, Hasumi K, Tominaga T. SMTP-7, a new
thrombolytic agent, decreases hemorrhagic transformation after transient middle
cerebral artery occlusion under warfarin anticoagulation in mice. Brain Res. 2014
Jul 9. pii: S0006-8993(14)00911-1. doi: 10.1016/j.brainres.2014.07.004. [Epub
ahead of print] PubMed PMID: 25016287.
)).